HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc18-0342
Institutions: Medizinische Hochschule Hannover, Kinderkrankenhaus auf der Bult, Inserm, Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique de Nantes, Institut du Thorax, Lexicon Pharmaceuticals (United States), Kantonsspital St. Gallen, Mossakowski Medical Research Institute, Polish Academy of Sciences, Polish Academy of Sciences, Baylor College of Medicine, Texas Children's Hospital, The University of Texas Southwestern Medical Center, University of Southern California
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2809590939
